High mobility group box 1 induces a negative inotropic effect on the left ventricle in an isolated rat heart model of septic shock - A pilot study

Circulation Journal

Volumn 72, Issue 6, 2008, Pages 1012-1017

  Hagiwara, Satoshi ^a   Iwasaka, Hideo ^a   Uchino, Tomoko ^a   Noguchi, Takayuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Cardiac function; HMGB1; Negative inotropic; Sepsis

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; RECOMBINANT HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HISTOPATHOLOGY; IMMUNOBLOTTING; INOTROPISM; MALE; NONHUMAN; PILOT STUDY; PROTEIN EXPRESSION; RAT; SEPTIC SHOCK;

ANIMALS; DISEASE MODELS, ANIMAL; HEART RATE; HMGB1 PROTEIN; LIPOPOLYSACCHARIDES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PILOT PROJECTS; RATS; RATS, WISTAR; SHOCK, SEPTIC; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 45849104173     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.1012     Document Type: Article

References (20)

1. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002; 5: 376-388.
2. Reilly JM, Cunnion RE, Burch-Whitman C, Parker MM, Shelhamer JH, Parrillo JE. A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest 1989; 95: 1072-1080.
3. Ognibene FP, Parker MM, Natanson C, Shelhamer JH, Parrillo JE. Depressed left ventricular performance: Response to volume infusion in patients with sepsis and septic shock. Chest 1988; 93: 903-910.
4. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100: 483-490.
5. Natanson C, Danner RL, Elin RJ, Hosseini JM, Peart KW, Banks SM, et al. Role of endotoxemia in cardiovascular dysfunction and mortahty: Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 1989; 83: 243-251.
6. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999; 19: 5237-5246.
7. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003; 101: 2652-2660.
8. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, et al. High mobility group box 1 protein (HMGB1) interacts with multiple Toll like receptors. Am J Physiol Cell Physiol 2006; 290: 917-924.
9. Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005; 61: 1-9.
10. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
11. Hagiwara S, Iwasaka H, Matumoto S, Noguchi T. Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7. Shock 2007; 27: 429-435.
12. Meng X, Ao L, Brown JM, Fullerton DA, Banerjee A, Harken AH. Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock 1997; 7: 111-118.
13. Meng X, Brown JM, Ao L, Banerjee A, Harken AH. Norepinephrine induces cardiac heat shock protein 70 and delayed cardioprotection in the rat through alpha 1 adrenoceptors. Cardiovasc Res 1996; 32: 374-383.
14. Meng X, Brown JM, Ao L, Nordeen SK, Franklin W, Harken AH, et al. Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats. Am J Physiol 1996; 271: C1316-C1324.
15. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183: 949-958.
16. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 2001; 164: 1768-1773.
17. Bonaldi T, Langst G, Strohner R, Becker PB, Bianchi ME. The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding. EMBO J 2002; 21: 6865-6873.
18. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004; 170: 1310-1316.
19. Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2007; 100: 204-212.
20. Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G, et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 2005; 97: e73-e83.